Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure

NCT07519005 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Hepatic Failure

Interventions

BIOLOGICAL: Ex vivo perfusion of six-gene-edited porcine liver
DRUG: Multi-drug immunosuppressive therapy

Sponsor

Xijing Hospital